Prostate Cancer Diagnosis and Treatment
Prostate cancer is the most commonly diagnosed solid-organ malignancy in men, and deciding how aggressively to treat it remains one of medicine's persistent dilemmas, since many tumors grow slowly enough that treatment side effects can outweigh survival benefit. Researchers use tools like multiparametric MRI, systematic biopsy, and Gleason grading to distinguish indolent disease from high-risk forms that warrant radiation, surgery, or androgen suppression. A central open question is how to reliably identify which patients can safely forgo immediate intervention through active surveillance versus those who need prompt treatment — a distinction that current imaging and pathology can approximate but not yet resolve with confidence. Longer-term work is pushing toward integrating genetic and molecular markers with clinical data to personalize treatment decisions and improve survival predictions beyond what population-level statistics currently allow.
- Works
- 126,272
- Total citations
- 1,991,570
- Keywords
- Prostate CancerScreeningRadiation TherapyGleason GradingMRI ImagingAndrogen Suppression
Top papers in Prostate Cancer Diagnosis and Treatment
Ordered by total citation count.
- Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer↗ 5,742
- Decision Curve Analysis: A Novel Method for Evaluating Prediction Models↗ 5,728OA
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer↗ 5,524OA
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy↗ 4,603OA
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer↗ 4,531
- Abiraterone and Increased Survival in Metastatic Prostate Cancer↗ 4,422OA
- Screening and Prostate-Cancer Mortality in a Randomized European Study↗ 4,026OA
- Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer↗ 3,691OA
- The American Urological Association Symptom Index for Benign Prostatic Hyperplasia↗ 3,456
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer↗ 3,376
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial↗ 3,298
- The Molecular Taxonomy of Primary Prostate Cancer↗ 3,272OA
Active researchers
Top authors in this area, ranked by h-index.